• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Device Problem Migration or Expulsion of Device (1395)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 10/01/2010
Event Type  Injury  
Manufacturer Narrative
Age at event: mean age.Sex: gender of majority of patients.Date of event: estimate from information included in content.Journal article: efficacy and patency of primary stenting for hepatic venous outflow obstruction after living donor liver transplantation.Joo yeon jang, ung bae jeon, jung hwan park, tae un kim, jun woo lee, chong woo chu and je ho ryu doi: 10.1177/0284185116637247.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Protege and complete se self-expanding(se) stents were used during a study to investigate the efficacy and patency of primary stenting for hepatic venous outflow obstruction after living donor liver transplantation.The study was ongoing from october 2010 until december 2013 with 21 patients receiving 26 stents in 25 vessels.Average patient age was 53 y/o (range 41-65) and gender was majority male.Selective hepatic venography and stent placement were performed from the right internal jugular vein in all patients.A 0.035" hydrophilic guide wire and a 5f catheter were used to select each hepatic vein.Primary stent placement was performed with various stents depending on the case including protege and complete se stents.The stents were 8¿16 mm in diameter and 3¿12 cm long.Procedures were considered an immediate technical success when the hepatic venogram revealed alleviation of the hepatic venous anastomotic stenosis with fluent flow of contrast medium through the hepatic venous anastomosis.11 days post-procedure, one patient died of spontaneous intracranial hematoma despite successful stent insertion.Other complications included stent migration during the procedure.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6352518
MDR Text Key68113332
Report Number2183870-2017-00090
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 01/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/27/2017
Initial Date FDA Received02/23/2017
Supplement Dates Manufacturer Received01/27/2017
Supplement Dates FDA Received09/29/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-